Pharma: Other News To Note
Breckenridge Pharmaceutical Inc., of Boca Raton, Fla., and Alembic Pharmaceuticals Ltd., of Baroda, India, settled Paragraph IV patent litigation with Novartis AG, of Basel, Switzerland, concerning rivastigmine tartrate capsules, a generic version of Novartis' Exelon.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.